4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001062993-24-017564
Chief Commercial Officer, MRD acquired 5,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| BOBULSKY SUSAN Chief Commercial Officer, MRD | 2024-10-08 | Option exercise | +5,000 | $1.98 | $9,900 | 253,290 | D |
| Derivatives | |||||||
| BOBULSKY SUSAN Chief Commercial Officer, MRD | 2024-10-08 | Option exercise · Stock Option (right to buy) | −5,000 | 0 | D | ||
Loading xslF345X05/form4.xml…